Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -6,592 | N/A | N/A |
| Depreciation Amortization | 179 | N/A | N/A |
| Accounts receivable | -294 | N/A | N/A |
| Accounts payable and accrued liabilities | 705 | N/A | N/A |
| Other Working Capital | 23,881 | N/A | N/A |
| Other Operating Activity | -163 | 0 | 0 |
| Operating Cash Flow | $17,716 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,994 | N/A | N/A |
| Other Investing Activity | -1,255 | 0 | 0 |
| Investing Cash Flow | $-3,249 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 70,752 | 0 | 0 |
| Financing Cash Flow | $70,752 | $N/A | $N/A |
| Beginning Cash Position | 5,211 | N/A | N/A |
| End Cash Position | 90,430 | N/A | N/A |
| Net Cash Flow | $85,219 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | 17,716 | N/A | N/A |
| Capital Expenditure | -1,994 | N/A | N/A |
| Free Cash Flow | 15,722 | 0 | 0 |